PD153035 Hydrochloride_183322-45-4_CoA_MedChemExpress
分子结构图
1、盐酸醋丁洛尔（Acebutolol Hydrochloride）化学名：N-[3-乙酰基-4-[2羟基-3-[（1-甲基乙基）氨基]丙氧基]苯基]丁酰胺盐酸盐；英文名：N-[3-Acetyl-4-[2-hydroxy-3-[（l-methylethyl）amino]Propoxy ]phenyl ]butanamide hydrochloride分子式：C18H28N2O4·HCl分子量：371．891\对丁酰胺基苯酚3\对丁酰胺基苯乙酮5\2-羟基-5-丁酰胺基苯乙酮8\2-环氧乙基甲氧基-5-丁酰胺基-苯乙酮10\醋丁洛尔2、醋谷胺铝（Aceglutamide Aluminum）化学名：N2-乙酰-L-谷氨酰胺四羟基三铝英文名：N2-Acetyl-L-glutamine aluminium complcx分子式：C35H59Al3N10O24分子量：1084．861\N-乙酰谷酰胺3、阿克他利(Actarit)化学名：4-乙酰胺基苯乙酸英文名：4-(Acetylamino)benzeneacetic acid 分子式：C10H11NO3分子量：193．211\4-氨基苯乙酸2\4-氨基苯乙酸乙酯3\4-乙酰胺基苯乙酸乙酯4\4-乙酰胺基苯乙酸，阿克他利4、阿昔洛韦（Acyclovir）化学名：2-氨基1,9-二氢-9-[(2-羟基乙氧基)甲基]-6H-嘌呤-6-酮英文名：2-amino-l,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one 分子式：C8H11N5O3分子量：225．2１＼鸟嘌呤３＼９-(2-苯甲酰氧基乙氧基甲基) 鸟嘌呤４＼阿昔洛韦阿苯达唑(Albendazole)化学名：［５-(丙硫基)-l H-2-苯并咪唑基］氨基甲酸甲酯英文名：[5-(propylthio)-l H-benzimidazol-2-yl]carbamic acid methyl ester 分子式：C12H15O2S分子量：265．34１＼３-氯-6-硝基乙酰苯胺３＼2-硝基-5-丙硫基苯胺４＼4-丙硫基-邻苯二胺5＼2-氨基-5-丙硫基苯并咪唑===================================6、阿拉普拉(Alacepril)化学名：(S)-N-[l-[3-(乙酰硫基)-2-甲基丙酰]-L-脯氨酰]-L-苯丙氨酸英文名：(S)N-[l-[3-(Acetylthio)-2-methyl-l-oxopropyl]-L-prolyl]-L-phenylalanine 分子式：C20H26N2O5S分子量：406．501\l-(D-3-乙酰硫基-2-甲基丙酰)-L-脯氨酸2\L-苯丙氨酸-叔丁酯盐酸盐4\l-(D-3-乙酰硫基-2-甲基丙酰)-L-脯氨酰-L-苯丙氨酸-叔丁酯6\阿拉普拉7、阿氯芬酸(Alclofenac)化学名：3-氯-4-(2-丙烯氧)苯乙酸英文名：3-Chloro-4-(2-propenyloxy)benzeneacetic acid分子式：C11H11O3Cl分子量：2261\邻氯苯酚3\邻氯烯丙氧苯5\2-氯-4-氯甲基-烯丙氧苯6\3-氯-4-烯丙氧苯乙腈7\3-氯-4-(2-丙烯氧)苯乙酸,阿氯芬酸8、阿法骨化醇(Alfacalcidol)化学名：（1α，3β，5Z，7E）-9，10-并环胆甾-5，7，10（19）三烯-1，3-二醇英文名：（1α，3β，5Z，7E）-9，10-Secocholesta-5,7,10(19)-triene-1,3-diol分子式：C27H44O2分子量：400641\胆固醇2\ 3β-羟基-5α-胆甾烷-6-酮3\ 6-亚乙二氧基-5α-胆甾烷-3β-醇4\ 6-亚乙二氧基-胆甾烷-3 –酮4\\ 2α-溴-6-亚乙二氧基-胆甾烷-3-酮5\ 6-亚乙二氧基-l-胆甾烯-3-酮6\6-亚乙二氧基-lα ,2α–环氧胆甾烷-3-酮7\6,6-亚乙二氧基-胆甾烷-lα ,3(α,β)-双醇8\5α-胆甾烷-6-酮-lα,3(α,β)-双醇8\5α-胆甾烷-lα,3(α,β)-二乙酰氧-6-酮9\5α-胆甾烷-lα,3β-二乙酰氧-6-醇10\ lα,3β-二乙酰氧胆固醇10\\lα,3β-二乙酰氧-7-溴-胆固醇11\ lα,3β-二乙酰氧-胆甾-5,7-二烯12\ lα,3β-二乙酰氧-前维生素D313 lα,3β-二乙酰氧-维生素D314\ lα-羟维生素D39、阿明洛芬(Alminoprofen)化学名：2-[对-(2-甲基烯丙基)-氨基苯基]丙酸；α-甲基-4-[（2-甲基-2-丙烯基）氨基]苯乙酸英文名：α-Methyl-4-[(2-methyl-2-propenyl)amino]benzeneacetic acid分子式：C13H17NO2分子量：219．291\2-（对硝基苯基）丙酸甲酯2\2-（对氨基苯基）丙酸甲酯4\2-[对（2-甲基烯丙基）氨基苯基]丙酸甲酯盐酸盐5\阿明洛芬10阿普唑仑（Alprazolam）化学名：8-氯-l-甲基-6-苯基-4H-[1,2,4]三唑并[4,3-α][1,4]苯并二氮杂草英文名：8-Chloro-l-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-α][1,4]benzodiazepine 分子式：C17H13ClN4分子量：308．771\ (2-氨基础理论-氯苯基)-苯甲酮2\ 甘氨酸乙酯盐酸盐3\7-氯-5-苯基-2-氧代-2,3-二氢-l H-1,4苯并二氨杂卓5\7-氯-5-苯基-2-硫代-2,3-二氢-l H-1,4苯并二氮杂卓7\ 2-(2-乙酰肼基)-7-氯-5-苯基-3 H-1,4苯并二氮杂卓8\阿普唑仑11盐酸阿普洛尔(Alprenolo Hydrochloride)化学名：1-[(1-甲基乙基)氨基]-3-[2-(2-丙烯基)苯氧基]-2-丙醇盐酸盐英文名：1-[(1-Methylethyl)amino]-3-[2-(2-propenyl)phenoxy]-2-propanol hydrochloride 分子式：C15H23O2N·HCl分子量：285．821\ 2-丙烯苯酚2\ 表氯醇3\ 1-(邻丙烯苯氧)-2,3-环氧丙烷5\1-(邻丙烯苯氧)-2-羟-3-异丙氨-丙烷,阿普洛尔12盐酸氨溴索(Ambroxol Hydrochloride)化学名：4-[[(2-氨基-3,5-二溴苯基)甲基]氨基]环已醇盐酸盐英文名：4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol hydrochloride 分子式：C13H18Br2N2O·HCl分子量：414．571\ 2-氨基-3,5-二溴-N-(羟基环已基)苯甲酰胺2\ 4-(2-氨基-3,5-二溴苄胺基)-环已醇3\ 盐酸氨溴索13氨芬酸钠(Amfenac Sodium)化学名：2-氨基-3-苯甲酰苯乙酸钠二水合物英文名：2-Amino-3-benzoylbenzeneacetic acid sadinmsalt dihydrate 分子式：C15H2NO3Na·2H2O分子量：277．181\ 1-氨基-1,3-二氢吲哚-2-酮2\苯基丙酮3\1-(2-甲基苯亚乙基亚氨基)1,3-二氢吲哚-2-酮4\ 2-(2-甲基-3-苯基吲哚-7-基)乙酸乙酯5\ 2-乙酰胺基-3-苯甲酰苯乙酸乙酯6\ 7-苯甲酰1,3-二氢吲哚-2-酮7\ 2-氨基-3-苯酰苯乙酸8\氨芬酸钠14苯磺酸氨氨地平(Amlodipine Besilate)化学名：(±)-2-(2-氨基乙氧甲基)-4-(2-氯苯基)-1,4-二氢-6-甲基-3,5-吡啶二羧酸-3-乙酯-5-甲酯苯磺酸盐英文名：(±)-2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxy lic acid-3-ethyl-5-methylester Benzenesulfonate分子式：C20H25ClN2O5·C6H5SO3H分子量：567．06１、２-氯苯甲醛２、乙酰乙酸甲酯３、2-（2-氯苄叉基）乙酰乙酸甲酯４、4-氯-3-氧代丁酸乙酯，氯乙酰乙酸乙酯５、2-叠氮乙醇６、2-叠氮乙氧基乙酰乙酸乙酯７、2-[（2-叠氮乙氧基）甲基]-4-（2-氯苯基）-3-乙氧羰基-5-甲氧羰基-6-甲基-1，4二氢吡啶氨氯地平15盐酸氨磺洛尔（Amosulalol Hydrochloride）化学名：5-(±)-5-[1-羟基-2-[[2-(2-甲氧基苯氧基)乙基]氨基]乙基]-2-甲基苯磺酰胺盐酸盐英文名：5-(±)-5-[1-Hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methylbenzenesalfonamide hydrochloride分子式：C18H24N2O5S·HCl分子量：416．931\ 5-溴乙酰-2-甲基苯磺酰胺2\ N-[2(2-甲氧基)苯氧基乙基]苄胺3\ 5-[N-苯甲基-N-[[2-(2-甲氧基)苯氧基]乙基]氨基]乙酰-2-甲基苯磺酰胺4\ 5-[1-羟基-2-[[N-苯甲基-N-2-(2-甲氧基)苯氧基乙基]氨基]乙基]-2-甲基苯磺酰胺5\5-[1-羟基-2-[[2-(2-甲氧基苯氧基)乙基]氨基]乙基]-2-甲基苯磺酰胺盐酸盐,盐酸氨磺洛尔16阿莫西林(Amoxicillin)化学名：[2S-[2α,5α,6β(S﹡)]]-6-[[氨基(4-羟苯基)乙酰基]氨基]-3,3-二甲基-7-氧代-4-硫-1-氮杂二环[3,2,0]庚烷-2-羧酸英文名：[2S-[2α,5α,6β(S ﹡)]]-6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]h eptane-2-carboxylic acid分子式：C16H19N3O5·3H2O分子量：419．411\ ( ±)苄氧甲酰氨-4-羟苯乙酸2\ (－)苄氧甲酰氨-对羟苯乙酸3\ 6-氨基-青霉烷酸4\6-[(－)-苄氧甲酰氨-对羟基苯乙酰胺]青霉烷酸5\ 阿莫西林17氨苄西林(Ampicillin)化学名：[2S-[2α,5α,6β(S﹡)]]-6-[(氨基苯乙酰)氨基]-3,3-二甲基7-氧代-4-硫杂-1-氮杂二环[3,2,0]庚烷-2-羧酸英文名：[2S-[2α,5α,6β(S ﹡)]]-6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]heptane-2-car boxylic acid分子式：C16H19N3O4S分子量：．349．421\D(－)-α-氨基-α-苯乙酸2\ 氯甲酸苄酯3\ D(－)-苄氧基甲酰氨基-α-苯乙酸4\ 氯甲酸乙酯5\[3]和[4]的混合酸无水物6\ 6-氨基青霉烷酸7\ 6-[D(－)-α-(苄氧基甲酰氨基)苯乙酰氨]青霉烷酸8\氨苄西林18、氨力农（Amrinone）化学名：5-氨基-(3,4′-双吡啶)-6(1H)-酮英文名：5-Amino-(3,4′-bipyridin)-6(1H)-one 分子式：C10H9N3O分子量：187．201\ 4-甲基吡啶2\ 2-(4-吡啶基)-3-二甲胺基丙烯醛3\ 氰基乙酰胺4\ 3-氰基-5-(-4-吡啶基)-2(1H)-吡啶酮5\ 3-氨甲酰基-5-(-4-吡啶基)-2(1H)-吡啶酮19\阿加曲班(Argatroban)化学名：1-[5-[(氨基亚氨基甲基)氨基]-1-氧代-2[[(1,2,3,4四氢-3-甲基-8-喹啉基)磺酰]氨基]戊基]-4-甲基-2-哌啶羧酸英文名：1-[5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]a mino]pentyl]-4-methyl-2-piperidinecarboxylic acid分子式：C23H36N6O5S分子量：508．6420盐酸阿罗洛尔(Arotinolol Hydrochloride)化学名：(±)-5-[2-[[3-[(1,1-二甲基乙基)氨基]-2-羟基丙基]硫]-4-噻唑基]-2-噻吩酰胺盐酸盐英文名：(±)-5-[2-[[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-2-thiophenecarboxa mide hydrochloride分子式：C15H21N3O2S3·HCl分子量：．408．11\ 5-乙酰基噻吩-2-羧酸2\ 5-乙酰噻吩-2-甲酰氨3\ 5-溴乙酰噻吩-2-甲酰氨4\ 二硫代氨基甲酸铵5\ 5-(2-巯基4-噻唑基)-2-噻吩甲酰氨7\ 5-[2-(3’-叔丁基氨基-2’-羟基丙基硫)-4-噻唑基]-2-噻吩甲酰氨8\ 盐酸阿罗洛尔21阿司咪唑(Astemizole)化学名：1-[(4-氟苯基)甲基]-N-[1-[2-(4-甲氧苯基)乙基]-4-哌啶基]-1H-2-苯并唑咪基胺英文名：1-[(4-Fluorophenyl)methyl] -N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl] -1H-benzimidazol-2-amine分子式：C28H31FN4O分子量：．458．251\ 1-异硫氰基-2-硝基苯酯2\ 4-氨基-1-哌啶甲酸乙酯3\ N-(2-硝基苯基)-N’-(1-乙氧甲酰-4-哌啶基)硫脲4\ N-(2-氨基苯基)-N’-(1-乙氧甲酰-4-哌啶基)硫脲5\ 2-(1-乙氧甲酰-4-哌啶基氨基)苯并咪唑6\ 4-氟苄基氯7\1-(4-氟苄基)-2-(1-乙氧甲酰-4-哌啶基氨基)苯并咪唑8\1-(4-氟苄基)-2-(4-哌啶基氨基)苯并咪唑9\甲磺酸对甲氧苯基乙酯10 阿司咪唑22阿替洛尔(Atenolol)化学名：4[2-羟基-3-[(1-甲基乙基)氨基]丙氧基]苯乙酰胺英文名：4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide 分子式：C14H22N2O3分子量：266．341\ 2-(4-环氧乙烷基甲氧苯基)-乙酰胺2\ 异丙胺3\1-对氨基甲酰甲基苯氧基-3-异丙胺基-2-丙醇,阿替洛尔23盐酸阿扎司琼(Azasetron Hydrochloride)化学名：（±）-N-1-氮杂二环[2,2,2]-3-辛基-6-氯-3,4-二氢-4-甲基-3-氧代-2H-1,4-苯并噁嗪-8-甲酰胺盐酸盐英文名：（±）-N-1-Azabicyclo[2,2,2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carb oxamide hydrochloride分子式：C17H20ClN3O3·HCl分子量：368．281\ 5-氯-2-羟基苯甲酸甲酯2\ 5-氯-2-羟基-3-硝基苯甲酸甲酯3\ 5-氯-2-羟基-3-氨基苯甲酸甲酯5\氯乙酰氯6\ 6-氯-4-甲基-3-氧代-3，4-二氢-2H-1，4-苯并噁嗪-8-甲酸甲酯7\ 6-氯-4-甲基-3-氧代-3，4-二氢-2H-1，4-苯并噁嗪-8-甲酸8\ 6-氯-4-甲基-3-氧代-3，4-二氢-2H-1，4-苯并噁嗪-8-甲酰氯9\ 1-氮杂-3-二环[2，2，2]辛基胺10\ 盐酸阿扎司琼24盐酸氮卓斯丁（Azelastine Hydrochloride）化学名：4-[(4-氯苯基)甲基]-2-(六氢-1-甲基-1H-4-氮杂卓基)-1(2H)-酞嗪酮盐酸盐英文名：4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinonehydroc hloride分子式：C22H25N3Cl2O分子量：418．371、2-4氯苯乙酰酰基苯甲酸2、硫酸肼3、4-（4-氯苄基）-1（2H）-酞嗪酮2-（2-氯乙基）-N-甲基吡咯烷盐酸盐5、4-（4-氯苄基）-2[N-甲基全氢化氮杂卓基-（4）-]-1（2H）-酞嗪酮6、4-（4-氯苄基）-2-[N-甲基全氢化氮杂卓基-（4）-]-1-（2H）酞嗪酮盐酸盐，盐酸氮卓斯丁25奥（Azulene）化学名：环戊二烯并环庚三烯英文名：Cyclopentacycloheptene 分子式：C10H8分子量：128．161\ 1,6-己二酸2\ 6-羰基-壬二酸3\ 5-(2-乙酰基-1-环戊烯基)-戊酸4\ 2,3,5,6,7,8-六氢-1H–奥-4-酮5\ 八氢,奥-4-酮6\ 十氢奥-4-醇7\奥26盐酸巴氨西林(Bacampicillin Hydrochloride)化学名：[2S-[2α,5α,6β(S﹡)]]-6-[(氨基苯基乙酰)氨基]-3,3-二甲基-7-氧代4-硫杂-1-氮杂二环[3,2,0]庚烷-2-羧酸-1-[(乙氧羰基)氧基]乙酯盐酸盐英文名：[2S-[2α,5α,6β(S﹡)]]-6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]heptane-2-car boxylic acid 1-[(ethoxycarbonyl)oxy]ethyl ester hydrochloride分子式：C21H27N3O7S·HCl分子量：502．001\ 碳酸-1-氯乙酯乙酯3\碳酸-1-溴乙酯乙酯4\ 6-[(氨基苯基乙酰)氨基]-3,3-二甲基7-氧代号-硫杂志-氮杂二环[3,2,0]庚烷-2-羧酸5\ 乙酰乙酸甲酯6\ 6-[2-(甲氧羰基)-1-甲基乙烯基氨基苯基(乙酰)氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂二环[3,2,0]庚烷-2-羧酸7\ 盐酸巴氨西林27巴氯芬(Baclofen)化学名：β-(氨甲基)-4-氯苯丙酸英文名：β-(Aminomethyl)-4-chlorobenzenepropanoic acid分子式：C10H12ClNO2分子量：213．661\ 对氯肉桂酸乙酯2\ 硝基甲烷3\ β-硝甲基4-氯苯丙酸乙酯4\ 4-(对氯苯)-2-吡咯烷酮28苄达酸(Bendazac)化学名：[(1-苄基-1H-3-吲唑基)氧基]乙酸英文名：[(1-Phenylmethyl) -1H-indazol-3-yl]-oxy]-acetic acid 分子式：C16H14H2O3分子量：282．301\ 1-苄基-1H-3-吲唑醇钠2\ 氯乙晴3\ 1-苄-3-吲唑-氧乙腈4\ 苄达酸29盐酸苄丝肼(Benserazide Hydrochloride)化学名：DL-丝氨酸-2-[(2,3,4-三羟苯基)甲基]酰肼盐酸盐英文名：DL-Serine-2-[(2,3,4-trihydroxyphenyl)methyl]-hydrazidc hydrochloride 分子式：C10H15N3O5·HCL分子量：293．711\ DL-丝氨酰肼盐酸盐2\ 2,3,4-三羟苯甲醛3\ DL-丝氨酰-2-(2,3,4-三羟基亚苄基)酰肼盐酸盐4\ 盐酸苄丝肼30苯溴马隆(Benzbromarone)化学名：(3,5-二溴-4-羟基苯基)-(2-乙基-3-苯并呋喃)-甲酮英文名：(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)methanone 分子式：C17H12Br2O3分子量：424．091\ 水杨醛2\ 一氯丙酮3\2-乙酰苯并呋喃4\ 水合肼5\ 2-乙基苯并呋喃6\ 对甲氧基苯甲酰氯7\ 2-乙基3-茴香酰-苯井呋喃8\ 吡啶盐酸盐9\2-乙基地-3-(对-羟-苯甲酰)-苯并呋喃10\ 苯溴马隆31二丙酸倍他米松(Betamethasone Dipropionate)化学名：(11β,16β)-9-氟-11,17,21-三羟-16-甲基-孕甾-1,4-二烯-3,20-双酮-17,21-二丙酸酯英文名：(11β,16β)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate分子式：C28H37FO7分子量：504．591\ 9α-氟-11β,17α,21-三羟基-16β-甲基-5α-孕甾烷-3,20-二酮-21-乙酸酯3\ 11β三甲基硅烷氧基-9α-氟-17α,21-二羟基-16β-甲基-5α-孕甾烷-3,20-二酮-21-乙酸酯4\ 11β三甲基硅烷氧基-9α-氟-17α,21-二羟基-16β-甲基-5α-孕甾烷-3,20-二酮5\ 丙酸酐6\对甲苯磺酸7\11β三甲基硅烷氧基-9α-氟-17α,21-二羟基-16β-甲基-5α-孕甾烷-3,20-二酮-17,21-二丙酸酯8\ 2,3-二氯-5,6-二腈-苯醌(DDQ)9\ 11β三甲基硅烷氧-17α,21-二羟基-基-9α-氟-16β-甲基孕甾-1,4-二烯-3,20-二酮-17,21-二丙酸酯10\ 9α-氟-11β,17α,21-三羟基-16β-甲基孕甾-1,4-二烯-3,20-二酮-17,21-二丙酸酯, 二丙酸倍他米松32倍他米松磷酸钠(Betamethasone Sodium phosphate)化学名：9α-氟-11β,17α,21-三羟基-16β-甲基孕甾-1,4-二烯3,20-二酮-21-(二氢磷酸酯)二钠盐英文名：(11β,16β)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione-21-(dihydrogenph osphate)disodium salt分子式：C22H29FNaO8P分子量：494．431\ 3α-乙酰氧基-16-孕甾烯-11,20-二酮3\ 3α-乙酰氧基-16α,17α-亚甲偶氮孕甾-11,20-二酮4\ 3α-乙酰氧基-16-甲基-16-孕甾烯- 11,20-二酮6\ 16α,17α-环氧-3α-羟基-16β-甲基孕甾-11,20-二酮7\ 3α,17α-二羟基-16β-甲基孕甾- 11,20-二酮8\ 21-溴-3α,17α-二羟基-16β-甲基孕甾- 11,20-二酮10\ 3α,17α-21-三羟基-16β-甲基孕甾- 11,20-二酮-21-乙酸酯11\N-溴琥珀酰亚胺12\ 17α,21-二羟基-16β-甲基孕甾- 3,11,20-三酮-21-乙酸酯13\ 4-溴-17α,21-二羟基-16β-甲基孕甾-3, 11,20-三酮-21乙酸酯14\ 盐酸氨基脲15\ 17α,21-二羟基-16β-甲基-4-孕甾烯- 3,11,20-三酮-21-乙酸酯的-3-缩氨基脲16\ 17α,21-二羟基-16β-甲基-4-孕甾烯- 3,11,20-三酮-21-乙酸酯17\ 17α,21-二羟基-16β-甲基-4-孕甾烯- 3,11,20-三酮-21-乙酸酯的-3,20-二缩氨基脲19\11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3,,20-二酮的-3,20-二缩氨基脲20\ 11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3,20-二酮21\ 乙酐22\ 11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3,,20-二酮-21-乙酸酯23\ 甲磺酰氯24\ 17α,21-三羟基-16β-甲基-4,9(11)-孕甾二烯- 3,,20-二酮-21-乙酸酯25\ 9α-溴-11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-乙酸酯27\ 9β,11β-环氧- 17α,21-二羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-乙酸酯28\ 9α-氟-11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-乙酸酯30\9α-氟-11β,17α,21-三羟基-16β-甲基-1,4-孕甾二烯- 3, 20-二酮-21-乙酸酯31\倍他米松32\ 9α-氟-11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-甲磺酸酯33\ 9α-氟-16β-甲基-11β,17α–二羟基- 3, 20-二氧代-21-碘-1,4-孕甾二烯34\ 9α-氟-16β-甲基11β,17α,21-三羟基- 3, 20-二氧代1,4-孕甾二烯-21-磷酸二氢酯35\倍他米松磷酸钠33\盐酸贝凡洛尔(Bevantolol Hydrochloride)化学名：1-[[2-(3,4-二甲氧基苯基)乙基]胺基]-3-(3-甲苯氧基)-2-丙醇盐酸盐英文名：1-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol hydrochloride分子式：C20H27NO4·HCl分子量：381．901\ 3-甲基苯酚2\ 氯甲基环氧乙烷3\ 3-甲苯氧基环氧乙烷4\2-(3,4-二甲氧苯基)乙胺5\盐酸贝凡洛尔34\盐酸溴己新(Bromhexine Hydrochloride)化学名：2-氨基-3,5二溴-N-环已基- N-甲基苯甲铵盐酸盐英文名：2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemethanamine hydrochloride 分子式：C14H21N2Br2Cl分子量：412．631\ 2-硝基溴苄2\ N-甲基环已胺3\ N-(2-硝基苄)- N-甲基环已胺5\ N-(2-氨基苄)- N-甲基环已胺6\盐酸溴已新35\溴哌利多(Bromperidol)化学名：4[4-(4-溴苯基)-4羟基-1-哌啶基]-1-(4-氟苯基)-1-丁酮英文名：4[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl]-1-(-4-fluorophenyl)-1-butanone 分子式：C21H23BrFNO2分子量：420．331\4-溴苯基溴化镁2\ 1-(乙氧羰基)-4-氧代哌啶3\ 1-(乙氧羰基)-4-羟基-4-(4-溴苯基)哌啶4\ 4-羟基-4-(4-溴苯基)哌啶5\ 1-(4-氯丁酰)-4氟苯6\ 溴哌利多36\溴替唑仑(Brotizolam)化学名：2-溴-4-(2-氯苯基)-9-甲基-6H-噻嗯并-[3,2-f ]-[1,2,4]-三唑并-[4,3-α]-[1,4]-二氮杂卓英文名：2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno-[3,2-f ]-[1,2,4]-triazolo-[4,3-α]-[1,4]-diazepine 分子式：C22H19Br分子量：363．311\ 7-溴-5-(2-氯苯基)-1,3-二氢噻嗯-[2,3-e]-1,4-二氮杂卓-2-酮2\ 7-溴-5-(2-氯苯基)-1,3-二氢-[2,3-e]-噻嗯-1,4-二氮杂卓-2-硫酮3\ 7-溴-5-(2-氯苯基)-2-肼基-1,3-二氢-[2,3-e]- 噻嗯-1,4-二氮杂卓4\ 正乙酸二乙酯5\溴替唑仑37富马酸溴长春胺(Brovincamine Fumarate)化学名：(3α,14β,16α)-11-溴-14,15-二氢-14-羟基象牙烯宁-14-羧酸甲酯富马酸盐英文名：(3α,14β,16α)-11-Bromo-14-15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid methylester fumarate分子式：C21H25BrN2O3·C4H4O4分子量：549．351\ (3α,14β,16α)-长春胺2\溴长春胺38布地奈德（Budesonide）化学名：(11β,16α)-16,17-[亚丁基双(氧)]-11,21-二羟基孕甾-1,4-二烯-3-20-二酮英文名：(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione分子式：C25H34O6分子量：430．551\ 16α-羟基泼尼松龙2\布地奈德39\盐酸布那唑嗪(Bunazosin Hydrochloride)化学名：1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-6-氢-4-(1-氧代丁基)-1H-1,4-二氮卓盐酸盐英文名：1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-4-(1-oxobutyl)-1H-1,4-diazepinehydrochlo ride分子式：C19H27N5O3·HCl分子量：409．931\ 2-氯-4-氨基-6,7-二甲氧基喹唑啉2\ N-甲酰高哌嗪3\ 2-(N-甲酰高哌嗪基)-4-氨基-6,7二甲氧基喹唑啉4\ 2-高哌嗪基-4-氨基-6,7-二甲氧基喹唑啉盐酸盐5\ n-丁酰氯6\ 盐酸布那唑嗪40盐酸布尼洛尔(Bunitrolol Hydrochloride)化学名：2-[3-[(1,1-二甲基乙基)氨基]-2羟基丙氧基]苄腈盐酸盐英文名：2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]benzonitrile hydrochloride 分子式：C14H20ON2O2·HCl分子量：248．81\ 2-环氧乙烷甲氧基-苄腈3\盐酸布尼洛尔。
化妆品成分词典
化妆品成分词典（中英文对照及解释）AA|pha Lipoic Acid 硫辛酸具水溶及油溶双性超级抗氧化剂，可在细胞膜内外保护细胞和加强细胞之修复能力A|pha Tocopherol 维他命E 延缓细胞老化现象、可以防止疤痕帮助伤口愈合、抗氧化、减少老人斑的沈积。
卫生署规定成人之建食量每日为 25~30 mg Acrylates Copolymer 丙烯酸酯聚合体会吸收脸上油脂减少油光，搭配其它物质如甘油、环甲硅脂、维他命A醇、蔬菜油等于产品中时具有定时释放的特性藉此延长产品的效果及减少产品的直接刺激性Age Intervention Complex 含外用干扰素、Q10、有机硫MSM有修护受损细胞、抗自由基、抗炎、维护细胞膜等功能Algae Extract 海藻粹取物促进新陈代谢、具保湿作用、使皮肤柔软、抗炎、抗自由基Alkyl Benzoate 烃基安息香酸盐柔软剂All trans retinol A醇加速表皮细胞的生长、刺激胶原蛋白的增生、减缓发炎反应、抑制皮脂分泌、抗痘、抑菌Allantoin 尿囊素保湿、帮助愈合、抗炎、剌激细胞再生及舒缓的作用Almond Extract 杏仁粹取保湿及滋润作用，使肌肤柔软，其对肌肤的渗透性佳Aloe Vera 芦荟保湿、帮助愈合、抗炎、修复功能Aloe Barbadensis 翠绿芦荟，柔肤，缓和剂，保湿Aluminum Chlorohydrate 氢氯酸铝收敛剂、抑制腋臭Amino Acid 胺基酸最小分子结构之蛋白质，较易为皮肤吸收，具保湿作用Aminoguandine 柔软剂保持肌肤柔软滑润Aminophyllin 氨基比林镇静、散热Ammonium Laureth Sulfate(ALES) 十二酯硫酸铵天然月桂醇衍生之洗净剂Ammonium Lauryl Sulfate(ALS) 十二硫铵天然椰子醇衍生弱酸性洗净剂Apple (Pyrus malus) Extract 苹果粹取物抑制弹性纤维酵素破坏弹性纤维、抗老化Apricot Kernel Oil 杏核油含油酸、亚麻仁油酸及维他命A、E、柔润皮肤及保持弹性Arbutin 熊果素抑制酪胺酸酵素活性，具美白效果Arginine PCA PCA鲑卵酸酯保湿滋润，具效用之胺基酸及保湿剂。
鸦胆子素D
白头翁皂苷 B4 Anemoside B4 129741-57-7 HPLC≥98% 20mg/支 白鲜碱 DICTAMNINE 484-29-7 HPLC≥98% 20mg/支 白杨素 Chrysin 480-40-0 HPLC≥98% 20mg/支 百两金素 A Ardisiacrispin A 23643-61-0 HPLC≥98% 20mg/支 百秋李醇 Patchouli alcohol 5986-55-0 HPLC≥98% 20mg/支 百蕊草素 I Kaempferol-3-O-glucorhamnoside 40437-72-7 HPLC≥98% 20mg/支 斑蝥素 Cantharidin 56-25-7 HPLC≥98% 20mg/支 D-半乳糖 D-Galactose 59-23-4 HPLC≥98% 100mg/支 宝藿苷 I Baohuoside I 113558-15-9 HPLC≥98% 20mg/支 杯苋甾酮 Cyasterone 17086-76-9 HPLC≥98% 20mg/支 贝母素甲 Peimine 23496-41-5 HPLC≥98% 20mg/支 贝母素乙 Peiminine 18059-10-4 HPLC≥98% 20mg/支 贝母辛 Peimisine 19773-24-1 HPLC≥98% 10mg/支 鸦胆 子素 D
鸦胆子素 D
编码 品名 规格 20mg 北京华越洋生物 鸦胆子素 D GT155-20mg 100mg 北京华越洋生物 鸦胆子素 D GT355-100mg 中药化学对照品说明书 中文 鸦胆子 鸦胆子素 D 别 名 名 苦素 D 英文 来 源 鸦胆子 Bruceine D 名 分子 分子量 410.42 C20H26O9 式 白色针 CAS 21499-66-1 性 状 号 状结晶 检验标 含 量 HPLC≥98% HPLC 准 贮 藏 干燥、密闭、避光、低温（0-10℃） 抗肿瘤，抗阿米巴原虫的活性，体 药 性 外抗恶性疟 本品仅供实验室药品检测用，不作 其他用途 用 途 储存条件： 2-8℃ 检测方法： HPLC≥98% 单位 瓶 瓶
托马托花肽洒胶水产品说明说明书
SAFETY DATA SHEET1. IdentificationProduct identifierTomato Blossom Spray RTU Other means of identificationProduct code 32042Recommended use Agricutlural/ Horticultural Use- Foliar Fertilizer- Refer to product label Recommended restrictionsNone known.Manufacturer/Importer/Supplier/Distributor information Manufacturer Lawn and Garden Products, Inc.AddressPO Box 35000Company name Website Telephone Emergency Contact Number 1-559-994-9144Emergency phone numberCHEMTREC (24 hours):USA, Canada, Puerto Rico 1-800-424-3900E-mail Fresno, CA 937452. Hazard(s) identificationNot classified.Physical hazards Category 4Acute toxicity, oral Health hazardsCategory 2Skin corrosion/irritationCategory 2ASerious eye damage/eye irritationNot classified.Environmental hazards Not classified.OSHA defined hazardsLabel elementsSignal word WarningHazard statement Harmful if swallowed. Causes skin irritation. Causes serious eye irritation.Precautionary statementPreventionWash thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves. Wear eye/face protection.ResponseIf swallowed: Call a poison center/doctor if you feel unwell. If on skin: Wash with plenty of water. If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see this label). Rinse mouth. If skin irritation occurs: Get medical advice/attention. If eye irritation persists: Get medical advice/attention. Take off contaminated clothing and wash before reuse.Storage Store away from incompatible materials.DisposalDispose of contents/container in accordance with local/regional/national/international regulations.Hazard(s) not otherwise classified (HNOC)None known.Supplemental information99.28% of the mixture consists of component(s) of unknown acute oral toxicity.3. Composition/information on ingredientsMixturesCAS number% Chemical name Common name and synonyms7664-38-2Phosphoric AcidOther components below reportable levels99.27692544710.7230745526*Designates that a specific chemical identity and/or percentage of composition has been withheld as a trade secret.4. First-aid measuresInhalation Move to fresh air. Call a physician if symptoms develop or persist.Skin contact Remove contaminated clothing. Wash with plenty of soap and water. If skin irritation occurs: Getmedical advice/attention. Wash contaminated clothing before reuse.Eye contact Immediately flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, ifpresent and easy to do. Continue rinsing. Get medical attention if irritation develops and persists. Ingestion Rinse mouth. If vomiting occurs, keep head low so that stomach content doesn't get into the lungs.Get medical advice/attention if you feel unwell. Get medical attention if symptoms occur.Most importantsymptoms/effects, acute and delayed Symptoms may include stinging, tearing, redness, swelling, and blurred vision. May cause redness and pain. Severe eye irritation.Indication of immediate medical attention and special treatment needed Provide general supportive measures and treat symptomatically. Keep victim warm. Keep victim under observation. Symptoms may be delayed.General information Ensure that medical personnel are aware of the material(s) involved, and take precautions toprotect themselves. Show this safety data sheet to the doctor in attendance.5. Fire-fighting measuresSuitable extinguishing media Water fog. Foam. Dry chemical powder. Carbon dioxide (CO2).Unsuitable extinguishingmediaDo not use water jet as an extinguisher, as this will spread the fire.Specific hazards arising fromthe chemicalDuring fire, gases hazardous to health may be formed.Special protective equipmentand precautions for firefightersSelf-contained breathing apparatus and full protective clothing must be worn in case of fire.Fire-fightingequipment/instructionsMove containers from fire area if you can do so without risk.Specific methods Use standard firefighting procedures and consider the hazards of other involved materials. General fire hazards No unusual fire or explosion hazards noted.6. Accidental release measuresPersonal precautions, protective equipment and emergency procedures Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Wear appropriate protective equipment and clothing during clean-up. Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Ensure adequate ventilation. Local authorities should be advised if significant spillages cannot be contained. For personal protection, see section 8 of the SDS.Methods and materials for containment and cleaning up This product is miscible in water.Large Spills: Stop the flow of material, if this is without risk. Dike the spilled material, where this is possible. Cover with plastic sheet to prevent spreading. Absorb in vermiculite, dry sand or earth and place into containers. Following product recovery, flush area with water.Small Spills: Wipe up with absorbent material (e.g. cloth, fleece). Clean surface thoroughly to remove residual contamination.Never return spills to original containers for re-use. For waste disposal, see section 13 of the SDS.Environmental precautions Avoid discharge into drains, water courses or onto the ground.7. Handling and storagePrecautions for safe handling Do not taste or swallow. Avoid contact with eyes, skin, and clothing. Avoid contact with eyes. Avoidprolonged exposure. Provide adequate ventilation. Wear appropriate personal protectiveequipment. When using, do not eat, drink or smoke. Wash hands thoroughly after handling.Observe good industrial hygiene practices.Conditions for safe storage, including any incompatibilities Store in original tightly closed container. Keep container tightly closed. Store away from incompatible materials (see Section 10 of the SDS).8. Exposure controls/personal protectionOccupational exposure limitsUS. OSHA Table Z-1 Limits for Air Contaminants (29 CFR 1910.1000)Value Components TypePEL 1 mg/m3 Phosphoric Acid (CAS7664-38-2)US. ACGIH Threshold Limit ValuesValue Components TypeSTEL 3 mg/m3 Phosphoric Acid (CAS7664-38-2)TWA 1 mg/m3 US. NIOSH: Pocket Guide to Chemical HazardsValue Components TypeSTEL 3 mg/m3 Phosphoric Acid (CAS7664-38-2)TWA 1 mg/m3 Biological limit values No biological exposure limits noted for the ingredient(s).Appropriate engineering controls Good general ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. Eye wash facilities and emergency shower must be available when handling this product.Individual protection measures, such as personal protective equipmentEye/face protection Face shield is recommended. Wear safety glasses with side shields (or goggles).Skin protectionHand protection Wear appropriate chemical resistant gloves.Other Wear appropriate chemical resistant clothing. Use of an impervious apron is recommended.Respiratory protection In case of insufficient ventilation, wear suitable respiratory equipment. Respiratory protection notrequired.Thermal hazards Wear appropriate thermal protective clothing, when necessary.General hygiene considerations Keep away from food and drink. Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment to remove contaminants.9. Physical and chemical properties Appearance Liquid.Physical state Liquid.Form Liquid.Color Colorless Odor Slight. Pungent Odor threshold Not available. pH 2.2Salt-Out / Crystallization Temp Not available. Melting point/freezing point Not available. Initial boiling point and boilingrangeNot available. Flash point Not available. Evaporation rate Not available. Flammability (solid, gas)Not available. Upper/lower flammability or explosive limits Flammability limit - lower(%)Not available.Flammability limit - upper(%)Not available.Explosive limit - lower (%)Not available.Explosive limit - upper (%)Not available.Vapor pressure 0.00001 hPa estimated Vapor density Not available.Relative density Not available.Solubility(ies)Solubility (water)Miscible Partition coefficient (n-octanol/water)Not available.Auto-ignition temperature Not available.Decomposition temperature Not available.ViscosityNot available.Other informationPercent volatile98.49 % estimated Pounds per gallon8.38 lb/gal typical10. Stability and reactivityReactivity The product is stable and non-reactive under normal conditions of use, storage and transport.Chemical stability Material is stable under normal conditions.Possibility of hazardous reactionsNo dangerous reaction known under conditions of normal use.Conditions to avoid Contact with incompatible materials.Incompatible materials Strong oxidizing agents.Hazardous decomposition productsNo hazardous decomposition products are known.11. Toxicological informationInformation on likely routes of exposureIngestionHarmful if swallowed.Inhalation Prolonged inhalation may be harmful.Skin contact Causes skin irritation.Eye contactCauses serious eye irritation.Symptoms related to thephysical, chemical andtoxicological characteristics Symptoms may include stinging, tearing, redness, swelling, and blurred vision. Skin irritation.Severe eye irritation. May cause redness and pain.Information on toxicological effectsAcute toxicity Harmful if swallowed. Not known.Test ResultsComponentsSpeciesPhosphoric Acid (CAS 7664-38-2)LD50Rabbit Dermal Acute 2740 mg/kg LD50RatOral 1530 mg/kg* Estimates for product may be based on additional component data not shown.Skin corrosion/irritation Causes skin irritation.Serious eye damage/eyeirritationCauses serious eye irritation.Respiratory or skin sensitizationRespiratory sensitizationNot available.Skin sensitizationThis product is not expected to cause skin sensitization.Germ cell mutagenicity No data available to indicate product or any components present at greater than 0.1% aremutagenic or genotoxic.Carcinogenicity This product is not considered to be a carcinogen by IARC, ACGIH, NTP, or OSHA.OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050)Not listed.Reproductive toxicity This product is not expected to cause reproductive or developmental effects.Specific target organ toxicity -single exposureNot classified.Specific target organ toxicity -repeated exposureNot classified.Aspiration hazard Not available.Chronic effects Prolonged inhalation may be harmful.12. Ecological informationEcotoxicity The product is not classified as environmentally hazardous. However, this does not exclude thepossibility that large or frequent spills can have a harmful or damaging effect on the environment. Persistence and degradability No data is available on the degradability of this product.Bioaccumulative potential Not available.Mobility in soil No data available.Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creationpotential, endocrine disruption, global warming potential) are expected from this component. 13. Disposal considerationsDisposal instructions Collect and reclaim or dispose in sealed containers at licensed waste disposal site. Dispose ofcontents/container in accordance with local/regional/national/international regulations.Local disposal regulations Dispose in accordance with all applicable regulations.Hazardous waste code The waste code should be assigned in discussion between the user, the producer and the wastedisposal company.Waste from residues / unused products Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a safe manner (see: Disposal instructions).Contaminated packaging Empty containers should be taken to an approved waste handling site for recycling or disposal.Since emptied containers may retain product residue, follow label warnings even after container isemptied.14. Transport informationDOTNot regulated as dangerous goods.IATANot regulated as dangerous goods.IMDGNot regulated as dangerous goods.15. Regulatory informationUS federal regulations This product is a "Hazardous Chemical" as defined by the OSHA Hazard CommunicationStandard, 29 CFR 1910.1200.All components are on the U.S. EPA TSCA Inventory List.This product is not known to be a "Hazardous Chemical" as defined by the OSHA HazardCommunication Standard, 29 CFR 1910.1200.TSCA Section 12(b) Export Notification (40 CFR 707, Subpt. D)Not regulated.CERCLA Hazardous Substance List (40 CFR 302.4)Phosphoric Acid (CAS 7664-38-2)Listed.SARA 304 Emergency release notificationNot regulated.OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050)Not listed.Superfund Amendments and Reauthorization Act of 1986 (SARA)Hazard categories Immediate Hazard - YesDelayed Hazard - NoFire Hazard - NoPressure Hazard - NoReactivity Hazard - NoSARA 302 Extremely hazardous substanceNot listed.NoSARA 311/312 HazardouschemicalSARA 313 (TRI reporting)Not regulated.Other federal regulationsClean Air Act (CAA) Section 112 Hazardous Air Pollutants (HAPs) ListNot regulated.Clean Air Act (CAA) Section 112(r) Accidental Release Prevention (40 CFR 68.130)Not regulated.Not regulated.Safe Drinking Water Act(SDWA)US state regulationsUS. Massachusetts RTK - Substance ListPhosphoric Acid (CAS 7664-38-2)US. New Jersey Worker and Community Right-to-Know ActPhosphoric Acid (CAS 7664-38-2)US. Pennsylvania Worker and Community Right-to-Know LawPhosphoric Acid (CAS 7664-38-2)US. Rhode Island RTKPhosphoric Acid (CAS 7664-38-2)US. California Proposition 65WARNING: This product contains a chemical known to the State of California to cause cancer and birth defects or otherreproductive harm.International InventoriesCountry(s) or region Inventory name On inventory (yes/no)* Australia Australian Inventory of Chemical Substances (AICS)Yes Canada Domestic Substances List (DSL)Yes Canada Non-Domestic Substances List (NDSL)No China Inventory of Existing Chemical Substances in China (IECSC)Yes Europe European Inventory of Existing Commercial ChemicalYesSubstances (EINECS)Europe European List of Notified Chemical Substances (ELINCS)No Japan Inventory of Existing and New Chemical Substances (ENCS)No Korea Existing Chemicals List (ECL)No New Zealand New Zealand InventoryYes Philippines Philippine Inventory of Chemicals and Chemical SubstancesNo(PICCS)United States & Puerto Rico Toxic Substances Control Act (TSCA) InventoryYes *A "Yes" indicates that all components of this product comply with the inventory requirements administered by the governing country(s)A "No" indicates that one or more components of the product are not listed or exempt from listing on the inventory administered by the governingcountry(s).16. Other information, including date of preparation or last revisionIssue date07-21-2015Revision date07-22-2015Version #04Disclaimer Lawn and Garden Products cannot anticipate all conditions under which this information and itsproduct, or the products of other manufacturers in combination with its product, may be used. It isthe user’s responsibility to ensure safe conditions for handling, storage and disposal of theproduct, and to assume liability for loss, injury, damage or expense due to improper use. While theinformation contained herein are presented in good faith and believed to be accurate, it is providedfor your guidance only. Because many factors may affect processing or application, werecommend that you make tests to determine the suitability of a product for your particular purposeprior to use. No warranties of any kind, either expressed or implied, including warranties ofmerchantability or fitness for a particular purpose, are made regarding products described orinformation set forth, or that the products, or information may be used without infringing theintellectual property rights of others. In no case shall the information provided be considered apart of our terms and conditions of sale. Further, you expressly understand and agree that theinformation furnished by our company hereunder are given gratis and we assume no obligation orliability for the information given or results obtained, all such being given and accepted at your risk.。
压力蒸汽灭菌监测
2021/7/22
临床研究和试验结论
挤压问题不容小视！
2021/7/22
诊疗器械、器具和物品处理的操作流程
5.7 包装 5.7.9 封包要求
《消毒技术规范》：物 品捆扎不宜过紧，外用 化学指示胶带贴封。
5.7.9.2 闭合式包装应使用专用胶带，胶带
长度应与灭菌包体积、重量相适宜，松紧
适度。封包应严密，保持闭合完好性。 ➢ 封包胶带的长度应与灭菌包体积、重量相适宜 ➢ 棉布包装的手术器械包，封包胶带宜使用两条 ➢ 采用无纺布或纸包装的手术器械包或较大的无
采用物理、化学和生物监测法进行监测。 物理监测不合格的灭菌物品不得发放；并应
分析原因进行改进，直至监测结果符合要求。 包外化学监测不合格的灭菌物品不得发放，
包内化学监测不合格的灭菌物品不得使用。 并应分析原因进行改进，直至监测结果符合 要求。
2021/7/22
灭菌质量的监测通用要求
生物监测不合格时，应尽快召回上次生物监 测合格以来所有尚未使用的灭菌物品，重新 处理；并应分析不合格的原因，改进后，生 物监测连续三次合格后方可使用。
菌包应采用井子形或十字形封包方式 ➢ 封包松紧适度，封包应严密，保持闭合完好性 ➢ 不允许使用别针、绳子封包
2021/7/22
为何需要一定的弹性和伸缩性
伸缩性可以协助打包操作， 让封包略带有张力，闭合更稳定；
预真空过程，可造成包裹膨胀，伸缩性可 保证包裹始终处于良好闭合状态；
随着抽真空，包裹出现膨胀，伸缩性是关键
2021/7/22
测试结果判读
灭菌器状 态良好
2021/7/22
测试结果判读
灭菌器性能下 降
可安排检修
2021/7/22
精氨酸
L-盐酸精氨酸Cas 号: 15595-35-4别名: L-精氨酸盐酸盐;L-精氨酸单盐酸盐;L-胍基戊氨酸盐酸盐;L-盐酸蛋白氨基酸;L-盐酸胍基戊氨酸分子结构:描述: 1.L-盐酸精氨酸(15595-35-4)的生产方法：以明胶为原料，经酸性水解，再分离精制而得。
明胶[HCl,(水解)]→[116-122℃,16h]水解液[减压]→[(浓缩)]浓缩液[NaOH(中和)]→[pH10.5-11]中和液[缩合]→[pH8]苯亚甲基精氨酸粗品[HCl(水解)]→[煮沸]水解液[活性炭(脱色)]→脱色液[303×2树脂(吸附)]→[pH7-8]滤液[HCl(酸化)]→[pH3-3.5]酸化液[浓缩、结晶]→L-精氨酸盐酸盐。
苯亚甲基精氨酸粗品的制备：将明胶和2倍量工业盐酸放入水解罐内，加热于116-122℃回流16h，得水解液。
减压浓缩至1/2体积时，再加蒸馏水稀释至原体积，再浓缩，得浓缩液。
冷却后，缓缓加入30%NaOH溶液，不断搅拌，并使温度在10℃以下，调节pH至10.5-11，再缓缓滴加苯甲醛，当pH为8时，苯甲醛停止滴加，搅拌反应0.5h使其反应完成，苯亚甲基精氨酸结晶析出，静置6h后过滤，取结晶并用水洗涤，滤干，粉碎，于60℃干燥，得苯亚甲基精氨酸粗品。
粗品水解，分离纯化：在苯亚甲基精氨酸粗品中，加入其量0.8倍的6mol/L 盐酸，加热煮沸50min进行酸水解，水解至40min时，加入少量活性炭脱色，过滤，滤渣用热水洗涤，再过滤，合并洗涤液，静置分层。
分离出上层苯甲醛溶液待回收，下层水溶液，加入已处理好的弱碱性苯乙烯型阴离子树脂303×2，进行吸附，至pH7-8为止(约需3h)，滤去树脂，收集滤液。
再加6mol/LH Cl酸化收集得的滤液，使pH至3-3.5，加入适量活性炭，加热搅拌10min，过滤取滤液然后在水浴上保温80-90℃减压浓缩，至有少量结晶析出时，停止减压浓缩，冷却结晶，过滤取结晶先用70%乙醇洗涤，再用95%乙醇洗涤，滤干，于80℃干燥，得精制L-盐酸精氨酸(15595-35-4)。
Phanta超高保真酶
1.引物3’端最后一个碱基选择C或G； 2.引物3’端最后8个碱基应避免出现连续错配； 3.引物3’端尽量避免出现发夹结构； 4.引物Tm值控制在55℃-65℃之间； 5.引物额外附加序列，即与模板非配对序列，不应参与引物Tm值计算； 6.引物GC含量控制在40%-60%之间； 7.正向引物和反向引物Tm值以及GC含量尽可能一致。
应用实例
1.反应体系配制：
所有操作请在冰上进行，各组分解冻后请充分摇匀。为了防止PhantaTM Super-Fidelity DNA Polymerase的校对活性降解引物，请将聚合酶最后加入反应体系中。各组 分使用完毕后及时放回-20℃。5 × SF Buffer请勿长时间敞口放置。
ddH2O 5 × SF Buffer (with 10 mM MgSO4) 25 mM MgSO4a dNTP Mix (10 mM each)b
a. 对于大多数PCR反应，Mg2+最佳终浓度为1.5-2 mM。体系中已含有终浓度为2 mM Mg2+，如有需要，可用25 mM MgSO4，以0.2-0.5 mM为间隔向上摸索Mg2+最佳 使用浓度。
b. 请勿使用dUTP和带有尿嘧啶的引物或模板。 c. 扩增子GC含量>60%时加入终浓度3%的DMSO有可能会有助于扩增。 d. 推荐仅当扩增子GC含量>60%且优化条件也无法正常扩增时使用；可能会降低保真度。 e. 不同模板最佳反应浓度有所不同，下表为50 μl反应体系推荐模板使用量：
DMSOc
5 × PCR Enhancerd
模板DNAe
引物1 (10 μM)
引物2 (10 μM)
PhantaTM Super-Fidelity DNA Polymerase (1 U/μl)f
安捷伦产品目录
15
Real-Time PCR
16
Mx3000P QPCR System
17
Brilliant III Ultra-Fast SYBR Green QPCR and QRT-PCR Reagents
18
Brilliant III Ultra-Fast QPCR and QRT-PCR Reagents
Agilent / STRATAGENE
Agilent website: /genomics
Welgene | Agilent Stratagene
威健股份有限公司 | Stratagene 總代理
Table of Content
Table of Contents
/ XL1-Red Competent Cells SoloPack Gold Supercompetent Cells
/ TK Competent Cells Specialty Cells
/ Classic Cells / Fine Chemicals For Competent Cells
適用於 UNG 去汙染或 bisulphite
sequencing
適用於 TA Cloning
最高敏感性
取代傳統 Taq 的好選擇
-
2
威健股份有限公司 | Stratagene 總代理
PCR Enzyme & Instrument
Agilent SureCycler 8800
市場上領先的 cycling 速度和 sample 體積 10 ～ 100 μL 簡易快速可以選擇 96 well 和 384 well 操作盤 優秀的溫控設備讓各個 well 都能保持溫度的穩定 七吋的高解析度觸控螢幕讓操作上更為簡便 可以透過網路遠端操控儀器及監控儀器 Agilent 專業的技術支援可以幫助您應對各種 PCR 的問題
药品生产技术《盐酸氟西汀2015药典》
盐酸氟西汀Yansuan FuitingFluoetine HydrochlorideC17H18F3NO•HCl本品为〔士〕-N-甲基-3-苯基-3-〔4-三氟甲基苯氧基〕丙胺盐酸盐。
按枯燥品计算，含C17H18F3NO•HCl应为%～%。
【性状】本品为白色或类白色结晶性粉末；无臭。
本品在甲醇或乙醇中易溶，在水或三氯甲烷中微溶，在乙醚中不溶。
【鉴别】〔1〕在含量测定项下记录的色谱图中，供试品溶液主峰的保存时间应与对照品溶液主峰的保存时间一致。
〔2〕本品的红外光吸收图谱应与对照的图谱〔光谱集837图〕一致。
〔3〕本品的水溶液显氯化物鉴别〔1〕的反响〔通那么0301〕。
【检查】旋光度取本品，精密称定，加水-甲醇溶液〔15：85〕溶解并定量稀释制成每1ml中约含2021的溶液，依法测定〔通那么0621〕，旋光度为°至°。
酸度取本品适量，精密称定，加水适量，超声使溶解并定量稀释成每1ml中约含10mg的溶液，放冷，依法测定〔通那么0631〕，l中约含2021的溶液，溶液应澄清无色；如显浑浊，与1号浊度标准液〔通那么0902第一法〕比拟，不得更浓；如显色，与黄色1号标准比色液〔通那么0901第一法〕比拟，不得更深。
有关物质取本品约140mg，置25ml量瓶中，加流动相溶解并稀释至刻度，摇匀，作为供试品溶液；精密量取2ml，置100ml量瓶中，用流动相稀释至刻度，摇匀，精密量取5ml，置100ml量瓶中，用流动相稀释至刻度，摇匀，作为对照溶液；精密量取对照溶液5ml，置10ml量瓶中，用流动相稀释至刻度，摇匀，作为灵敏度溶液。
取盐酸氟西汀约22mg，置具塞试管中，加L硫酸溶液10ml，85℃水浴3小时，放冷，此溶液中含有杂质I和杂质II；取此溶液，置25ml量瓶中，分别取盐酸氟西汀约28mg、杂质Ⅲ对照品与杂质IV对照品各约1mg，置上述25ml 量瓶中，用流动相溶解并稀释至刻度，作为系统适用性溶液。
常见化工产品中英文对照记COA码总结
产品名称中文对照名称，俗称Indolebutyric acid吲哚丁酸Acetophenone乙酰苯Styrene苯乙烯Potassium perchlorate高氯酸钾Calcium chloride anhydrous氯化钙Ammonium bicarbonate碳酸氢铵Potassium dihydrogen phosphate磷酸二氢钾Sodium metabisulfite焦亚硫酸钠Aluminum sulfate硫酸铝Sodium dithionite亚硫酸氢钠Diammonium hydrogenphosphate磷酸氢二铵Lithium carbonate碳酸锂Ammonium persulfate过硫酸铵Ammonium chloride氯化铵 卤砂Hydrochloric acid盐酸Boric acid硼酸Ethylene glycol乙二醇Ammonium sulfate硫酸铵Trisodium phosphate磷酸三钠Sodium chloride氯化钠Potassium carbonate碳酸钾Potassium perchlorate高氯酸钾Potassium nitrate硝酸钾Sodium nitrate硝酸钠Sodium nitrite亚硝酸钠Barium nitrate硝酸钡Sodium sulfide nonahydrate九水硫化钠Phosphorus Pentoxide五氧化二磷calcium Hydroxide氢氧化钙STPP三聚磷酸钠calcium chloride氯化钙lithopone powder立德粉Chromic Green Oxide铬绿sodium formate甲酸钠Poly aluminum chloride（PAC）聚氯化铝ferric chloride氯化铁titanium dioxide钛白粉copper sulphate硫酸铜ferric oxide氧化铁calcium carbonate碳酸钙Wax蜡Glacial Acetic Acid冰醋酸aluminium sulfate硫酸铝oxalic acid草酸stearic acid硬脂酸formic acid甲酸carbon black炭黑zinc oxide氧化锌Titanium Dioxide anatase and rutile钛白粉 锐钛 ，金红石cas-no 133-32-4CAS-NO 98-86-2CAS No.: 7778-74-7 HS CODE:282990009099.0%min CAS No.: 1066-33-7CAS No.: 7778-77-0 HS CODE:283524000098% CAS No.: 7783-28-0 HS CODE:3105300001CAS No.: 554-13-2CAS No.: 12125-02-9HS CODE:2827109000CAS No.: 7647-01-0 HS CODE: 2806100000CAS No.: 10043-35-3 HS CODE:281000200099.50% EINECS number: 203-473-3CAS No.: 7783-20-2 HS CODE: 3102210000CAS No.: 7601-54-9 HS CODE:2835220000CAS No.: 7647-14-5 HS CODE:2501002000CAS No.: 584-08-7 HS CODE:2836400000CAS No.: 7778-74-7 HS CODE:2829900090CAS No.: 7757-79-1 HS CODE: 2834219000CAS No.: 7631-99-4 HS CODE:3102500000CAS No.: 7632-00-0 HS CODE:2834100000CAS No.: 10022-31-8 HS CODE:2834299001CAS NO. 1313-84-4CAS number: 1305-62-0CAS number: 7774-34-7Cas number: 1308-38-9CAS No.: 1327-41-9CAS number: 144-62-7CAS number: 144-62-7CAS No.: 1333-86-4 CAS: 1314-13-2。
小分子抑制剂、激动剂、拮抗剂--JAKSTAT信号通路
JAK/STAT
JAK/STAT（Janus激酶/信号转导子和转录激活子）信号通路将来自细胞外的化学信号传递给细胞核，导致与免疫、增殖、分化、凋亡和肿瘤发生等相关基因的DNA转录和表达。
此信号通路是众多细胞因子信号转导的共同途径，其活性在炎性疾病和血液恶性肿瘤等疾病治疗研究中具有重要意义。
JAK-STAT信号级联由三个主要成分组成：由酪氨酸激酶相关受体、酪氨酸激酶JAK和转录因子STAT三个成分组成。
JAK/STAT通路转导过程
细胞因子，如干扰素、白细胞介素和生长因子等配体，与细胞表面受体结合，引起受体分子二聚化。
与受体偶联的JAK 相互接近并通过交互的酪氨酸磷酸化而被激活。
活化后的JAK使受体的酪氨酸磷酸化，为具有SH2结构域的STAT创建结合位点。
STAT结合至受体后，在JAK作用下，STAT酪氨酸705（Tyr 705）被磷酸化。
STAT就会从受体上脱离，形成同/异二聚体。
STAT二聚体进入细胞核后，会结合特定的调节序列以激活或抑制靶基因的转录。
JAK/STAT信号通路图
按靶点分类：。
52-89-1,L-半胱氨酸,盐酸盐,技术规格说明书(SDS)
产品技术规格说明书由上海创赛科技有限公司收集整理，仅做参考使用。
L-半胱氨酸,盐酸盐详细介绍：
中文名称：
L-半胱氨酸,盐酸盐
中文别名：
L-半胱氨酸,盐酸盐;L-半胱氨酸盐酸盐水合物;L-丰胱胺酸盐酸盐;半胱氨酸,盐酸盐水合物;L-半胱氨酸盐酸盐(无水物);Α-氨基-Β-巯基丙酸盐酸盐;盐酸L-半胱氨酸;L-无水巯基丙氨酸盐酸盐;L-半胱氨酸盐酸盐无水物;DL-半胱氨酸盐酸盐;L-半胱氨酸盐酸盐,BR;L-半胱氨酸盐酸盐,无水;L―半胱氨酸盐酸盐无水物;L-半胱氨酸盐无水物;L-半胱胺酸盐酸盐;L-半胱胺酸盐酸盐无水物;L-巯基丙氨酸盐酸盐;L-盐酸半胱氨酸无水物;盐酸半胱氨酸;L-半胺氨酸盐酸盐;L-2-氨基-3-巯基丙酸盐酸盐;L-半胱氨酸盐酸盐-水物;L-无水半胱盐酸盐;半胱氨酸,盐酸盐;孚氨基酸;盐酸半胱氨酸(无水);L-半胱氨酸,盐酸盐,医药级,纯度:>99%
包装：
25, 100 g in poly bottle
生化/生理作用：
NMDA谷氨酸受体激动剂也是AMPA谷氨酸受体在高浓度时的激动剂。
查询关键词:“52-89-1，L-半胱氨酸,盐酸盐，L-Cysteine Hydrochloride，Sigma-Aldrich，上海现货”。
L-半胱氨酸,盐酸盐参考文献：
英文名称：
L-Cysteine hydrochloride
英文别名：
百灵威核磁耗材产品
NMR Consumables and Accessories
客服热线：400-666-7788
全球 NMR 耗材 引领 60 年
百灵威
百灵威科技有限公司成立于 1992 年，始终以“为科研和生产提供世界一流的产品和服务”为宗旨，致力于超精细化学品的研发与 制造。经过近二十年的发展，百灵威已具备为化学、分析、生物、材料、物理及药物研发等领域提供近五十万种产品和专业服务 的能力。 百灵威拥有一支强大的具有丰富经验和创新能力的研发团队，在江苏、河北设立的两个研发中心可迅速研发出毫克至数百公斤级 的医药、生化、材料等中间体及特殊高端化学品，并可为客户定制合成各类产品，尤其擅长小分子药物中间体以及催化剂配体的 合成。 百灵威人坚信“发展民族科技”的理念，坚持依靠中国人自己的智慧和力量， 不断建设和发展位于潮白河畔的现代化工业生产基地，发挥百灵威在尖端技术研究、敏捷制造和系统性物流管理等方面的突出优 势，积极地将中国的各种高端化合物推荐给国际同行，为促进中国化学事业发展，推动世界文明与和谐进步而奋斗不息。 百灵威的使命 促进科技和工业发展，造福人类……
管壁厚度(mm) 平均凸度(µm)
包装
0.27
<60>
50只/塑料筒装
0.27
<60>
50只/塑料筒装
0.43
<60>
50只/塑料筒装
0.43
<60>
100只/纸盒装
0.43
<60>
50只/塑料筒装
0.43
<60>
100只/纸盒装
0.60
<60>
50只/塑料筒装
SampleJet®核磁管
FDA兽药管理目录4
Section 2.0 - Active IngredientsApplicationActive Ingredients Trade NameNumber005-2362-Mercaptobenzothiazole Sulfodene® Medication for Dogs015-030Acepromazine Maleate PromAce® Injectable032-702Acepromazine Maleate PromAce® Tablets117-531Acepromazine Maleate Acepromazine Maleate Injection117-532Acepromazine Maleate Acepromazine Maleate Tablets200-319Acepromazine Maleate Acepromazine Maleate Injection200-361Acepromazine Maleate Acepromazine Maleate Injection011-582Acetazolamide Sodium Vetamox Soluble Powder011-700Acetylsalicylic Acid, Methylprednisolone Cortaba® Tablets141-406Afoxolaner NexGard™014-250Aklomide, Sulfanitran Novastat Type A Medicated Premix034-536Aklomide, Roxarsone Aklomix Type A Medicated Article, Aklomix-3034-537Aklomide, Roxarsone, Sulfanitran Novastat-3 Type A Medicated Article035-388Aklomide, Sulfanitran Novastat-W110-048Albendazole Valbazen®128-070Albendazole Valbazen®140-934Albendazole Valbazen®141-180Albuterol Sulfate Torpex™141-342Alfaxalone Alfaxan®131-310Altrenogest Regu-Mate®141-222Altrenogest Matrix®127-892Amikacin Sulfate Amiglyde-V200-178Amikacin Sulfate Amikacin Sulfate Injection200-181Amikacin Sulfate AmiMax™ E Solution043-078Aminopentamide Hydrogen Sulfate Centrine Oral Tablets043-079Aminopentamide Hydrogen Sulfate Centrine Injectable092-116Aminopentamide Hydrogen Sulfate, Ketamine Ketaset® PlusHydrochloride, Promazine Hydrochloride011-877Aminopropazine Fumarate Jenotone Tablets013-181Aminopropazine Fumarate, Neomycin Sulfate Jenomycin Tablets034-477Aminopropazine Fumarate Jenotone Solution120-299Amitraz Mitaban® Liquid Concentrate009-339Ammonium Chloride, Caramiphen Edisylate Carafen Cough Syrup, Carafen Cough Tablets055-078Amoxicillin Trihydrate Amoxi-Tabs055-080Amoxicillin Trihydrate Amoxi-DoserFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 1 of 70Number055-081Amoxicillin Trihydrate Amoxi-Tabs055-085Amoxicillin Trihydrate Amoxi-Drop® Oral Suspension055-087Amoxicillin Trihydrate Amoxi-Bol055-088Amoxicillin Trihydrate Amoxi-Sol055-089Amoxicillin Trihydrate Amoxi-Inject (Cattle)055-091Amoxicillin Trihydrate Amoxi-Inject (Dogs and Cats)055-099Amoxicillin Trihydrate, Clavulanate Potassium Clavamox® Tablets055-100Amoxicillin Trihydrate Amoxi-Mast055-101Amoxicillin Trihydrate, Clavulanate Potassium Clavamox® Drops065-492Amoxicillin Trihydrate Biomox065-495Amoxicillin Trihydrate Biomox®141-004Amoxicillin Trihydrate Robamox®-V141-005Amoxicillin Trihydrate Robamox®-V TabletsKanfosone Ointment043-784Amphomycin Calcium, Hydrocortisone Acetate,Kanamycin Sulfate047-997Amphomycin Calcium, Hydrocortisone Acetate,Amphoderm OintmentKanamycin Sulfate055-013Ampicillin Anhydrous Omnipen 250 mg055-084Ampicillin Sodium Amp-Equine200-335Ampicillin sodium Ampicillin Sodium055-030Ampicillin Trihydrate Polyflex®055-036Ampicillin Trihydrate Princillin Capsules 125 mg, Princillin Capsules 250 mg,Princillin Capsules 500 mg055-042Ampicillin Trihydrate Ampi-Tab055-050Ampicillin Trihydrate Princillin Soluble Powder055-056Ampicillin Trihydrate Princillin Bolus055-061Ampicillin Trihydrate Princillin "125" For Oral Suspension055-064Ampicillin Trihydrate Princillin Injection055-066Ampicillin Trihydrate Princillin Injection055-071Ampicillin Trihydrate Princillin Injection 200 mg055-074Ampicillin Trihydrate Ampi-Bol055-079Ampicillin Trihydrate Ampi-Ject200-180Ampicillin Trihydrate Ampicillin Trihydrate012-350Amprolium Amprovine 25%, CORID® 25% Type A Medicated Article 013-149Amprolium Amprovine 9.6% Solution013-461Amprolium, Ethopabate, Roxarsone Broiler PMX No.1620, Amprol Plus®, Amprol Hi-E®, AmprolPlus + Nitro®013-663Amprolium Purina® Liquid Amprol033-165Amprolium Amprovine 20% Soluble Powder, Corid 20% Soluble Powder FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 2 of 70NumberAmprol HI-E® Plus036-304Amprolium, Bacitracin Methylene Disalicylate,EthopabateAmp Ethopabate CTC® Sodium Sulfate 036-361Amprolium, Chlortetracycline Calcium Complex,Ethopabate, Sodium SulfateErythro® (Low Lev) / Amp plus Etho 038-242Amprolium, Arsanilic Acid, ErythromycinThiocyanate, Ethopabate041-178Amprolium, Ethopabate, LincomycinAmprol® Plus / Lincomix® / RoxarsoneHydrochloride Monohydrate, RoxarsoneLincomix® / Amprol Plus044-820Amprolium, Ethopabate, LincomycinHydrochloride Monohydrate049-179Amprolium, Ethopabate, Roxarsone Amprol HI-E® / RoxarsoneAmprol HI-E® / BMD® / Roxarsone 049-180Amprolium, Bacitracin Methylene Disalicylate,Ethopabate, Roxarsone095-543Amprolium, Bambermycins, Ethopabate Amprol HI-E® & Bambermycins, Amprol HI-E® / Flavomycin®3-Nitro® / Amprol HI-E® / Flavomycin®095-547Amprolium, Bambermycins, Ethopabate,Roxarsone095-548Amprolium, Bambermycins, Roxarsone3-Nitro® / Amprol / Flavomycin®095-549Amprolium, Bambermycins, Ethopabate,3-Nitro® / Amprol / Flavomycin®RoxarsoneAmprol HI-E® / Baciferm® / 3-Nitro®105-758Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone114-794Amprolium, Bacitracin Zinc, Ethopabate Baciferm® / Amprol HI-E® Premix118-507Amprolium, Carbarsone Amprol® / Carb-O-Sep®122-822Amprolium, Ethopabate, Virginiamycin Amprol HI-E® / Stafac®130-185Amprolium, Bambermycins Flavomycin® / Amprolium3-Nitro® / Amprol® / BMD®141-142Amprolium, Bacitracin Methylene Disalicylate,Roxarsone141-156Amprolium, Bacitracin Methylene Disalicylate Amprol® / BMD®200-205Amprolium, Bacitracin Zinc, Ethopabate Albac® / Amprol Hi-E®3-Nitro® / Albac® / Amprol Hi-E®200-214Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone3-Nitro® / Albac® / Amprol Hi-E®200-217Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone200-389Amprolium Amprolium 9.6% Oral Solution200-463Amprolium Amprolium 9.6% Oral Solution200-464Amprolium Ampromed™ for Calves200-482Amprolium AmproMed™ for Calves200-488Amprolium Ampromed™ P for Poultry200-496Amprolium AmproMed™ P for Poultry200-514Amprolium Boviprol™ 9.6% Oral Solution106-964Apramycin Sulfate Apralan® Soluble Powder126-050Apramycin Sulfate Apralan® 75 Soluble PowderErythro® (High Lev) / Zoalene plus Arsanilic Acid 038-241Arsanilic Acid, Erythromycin Thiocyanate,ZoaleneFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 3 of 70Number038-242Amprolium, Arsanilic Acid, ErythromycinErythro® (Low Lev) / Amp plus EthoThiocyanate, Ethopabate038-624Arsanilic Acid, Erythromycin Thiocyanate Pro-Gallimycin-10006-623Arsenamide Sodium Caparsolate Sodium141-033Atipamezole Hydrochloride Antisedan®013-248Atropine, Trichlorfon Freed No. 10, Freed No. 25035-650Atropine, Trichlorfon Dyrex Powder042-548Attapulgite, Bismuth Subcarbonate, KanamycinAmforol® SuspensionSulfateAmforol® Veterinary Oral Tablets042-841Attapulgite, Bismuth Subcarbonate, KanamycinSulfate115-732Azaperone Stresnil InjectionAmprol HI-E® Plus036-304Amprolium, Bacitracin Methylene Disalicylate,Ethopabate039-646Bacitracin Methylene Disalicylate, Carbarsone Carb-O-GainBMD® 15 / Coyden 25®041-541Bacitracin Methylene Disalicylate, Clopidol,Roxarsone046-592Bacitracin Methylene Disalicylate BMD® 50 Granular A Type A Medicated Article, BMD® 30Type A Medicated ArticleAmprol HI-E® / BMD® / Roxarsone 049-180Amprolium, Bacitracin Methylene Disalicylate,Ethopabate, Roxarsone049-463Bacitracin Methylene Disalicylate, Monensin USP Coban® plus BMD®Coban® plus 3-NITRO® plus BMD®049-464Bacitracin Methylene Disalicylate, MonensinUSP, RoxarsoneEntromycin Powder065-107Bacitracin Methylene Disalicylate, StreptomycinSulfate065-280Bacitracin Methylene Disalicylate Soluble Fortracin Concentrate065-470Bacitracin Methylene Disalicylate BMD® Soluble, BMD® Soluble 50%, Solu-tracin 200, Solu-tracin 50Bac MD / Robenz®097-085Bacitracin Methylene Disalicylate, RobenidineHydrochloride098-378Bacitracin Methylene Disalicylate, Nicarbazin Nicarb® 25% and bacitracin methylene disalicylate099-150Bacitracin Methylene Disalicylate, Clopidol BMD® / Coyden 25®107-996Bacitracin Methylene Disalicylate, Lasalocid Avatec® / Fortracin Premix3-Nitro® / Avatec® / BMD®116-082Bacitracin Methylene Disalicylate, Lasalocid,Roxarsone116-088Bacitracin Methylene Disalicylate, Monensin3-Nitro® / BMD® / Coban®, 3-Nitro® / Coban® / Fortracin Sodium, Roxarsone3-Nitro® / Avatec® / Fortracin Broiler Premix 131-894Bacitracin Methylene Disalicylate, Lasalocid,Roxarsone3-Nitro® / Bio-Cox® / BMD®135-321Bacitracin Methylene Disalicylate, Roxarsone,Salinomycin Sodium135-746Bacitracin Methylene Disalicylate, SalinomycinBio-Cox® / BMD®SodiumFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 4 of 70Number138-456Bacitracin Methylene Disalicylate, MonensinSodiumCoban® / BMD®140-533Bacitracin Methylene Disalicylate, HalofuginoneHydrobromide, Roxarsone3-Nitro® / BMD® / Stenorol®140-584Bacitracin Methylene Disalicylate, HalofuginoneHydrobromideBMD / Stenorol®140-852Bacitracin Methylene Disalicylate, Narasin,Roxarsone3-Nitro® / BMD® / Monteban®140-853Bacitracin Methylene Disalicylate, Narasin BMD® / Monteban®140-919Bacitracin Methylene Disalicylate, HalofuginoneHydrobromideBMD® / Stenorol®140-926Bacitracin Methylene Disalicylate, Narasin,NicarbazinBMD® / Maxiban®140-937Bacitracin Methylene Disalicylate, MonensinSodiumBMD® / Coban®141-058Bacitracin Methylene Disalicylate, Roxarsone,Semduramicin Sodium3-Nitro® / Aviax™ / BMD®141-059Bacitracin Methylene Disalicylate,Chlortetracycline BMD® 10, 25, 30, 40, 50, 60, 75 / CTC® 50, 65, 70, BMD® 25, 30, 40, 50, 60, 75 / ChlorMax™®- 50, 60, 70, MICRO-CTC® 100141-065Bacitracin Methylene Disalicylate, SemduramicinSodiumAviax™ / BMD®141-085Bacitracin Methylene Disalicylate, Zoalene BMD® / Zoamix®141-088Bacitracin Methylene Disalicylate, Nitarsone BMD® / Histostat®141-097Bacitracin Methylene Disalicylate, Ivermectin BMD® / Ivomec® Premix for Swine141-100Bacitracin Methylene Disalicylate, Decoquinate,Roxarsone3-Nitro® / BMD® / Deccox®141-102Bacitracin Methylene Disalicylate, Decoquinate BMD® / Deccox®141-112Bacitracin Methylene Disalicylate, Narasin,Nicarbazin, Roxarsone3-Nitro® / BMD® / Maxiban®141-121Bacitracin Methylene Disalicylate, Roxarsone,Salinomycin Sodium3-Nitro® / Bio-Cox® / BMD®141-124Bacitracin Methylene Disalicylate, Narasin,NicarbazinBMD® / Maxiban®141-136Bacitracin Methylene Disalicylate, SalinomycinSodiumBio-Cox® / BMD®141-138Bacitracin Methylene Disalicylate, Monensin,Roxarsone3-Nitro® / BMD® / Coban®141-140Bacitracin Methylene Disalicylate, Monensin BMD® / Coban®141-142Amprolium, Bacitracin Methylene Disalicylate,Roxarsone3-Nitro® / Amprol® / BMD®141-144Bacitracin Methylene Disalicylate, Fenbendazole BMD® / Safe-Guard®141-153Bacitracin Methylene Disalicylate, Diclazuril BMD® / Clinacox™141-154Bacitracin Methylene Disalicylate, RobenidineHydrochlorideBMD® / Robenz®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 5 of 70Number141-155Bacitracin Methylene Disalicylate, RobenidineHydrochloride, Roxarsone3-Nitro® / BMD® / Robenz®141-156Amprolium, Bacitracin Methylene Disalicylate Amprol® / BMD®141-179Bacitracin Methylene Disalicylate, Lasalocid Avatec® / BMD®141-190Bacitracin Methylene Disalicylate, Diclazuril,Roxarsone3-Nitro® / BMD® / Clinacox™141-194Bacitracin Methylene Disalicylate, Diclazuril BMD® / Clincox®141-195Bacitracin Methylene Disalicylate, Diclazuril Clinacox™/ Flavomycin®141-279Nicarbazin, Bacitracin methylene disalicylate Nicarb® 25% plus BMD®200-081Bacitracin Methylene Disalicylate, Roxarsone,Salinomycin Sodium3-Nitro® / BMD® / Sacox®200-082Bacitracin Methylene Disalicylate, SalinomycinSodiumBMD® / Sacox®200-164Bacitracin Methylene Disalicylate, Nicarbazin BMD® / Nicarmix 25®200-242Bacitracin Methylene Disalicylate,Chlortetracycline Calcium Complex BMD®-25, -30, -40, -50, -60, or -75 / Aureomycin® -50, -70, -80, -90 or -100200-358Bacitracin Methylene Disalicylate,Chlortetracycline HydrochloridePennchlor/ BMD044-016Bacitracin Zinc, Clopidol, Roxarsone Coyden 25® with Roxarsone and Bacitracin Zinc045-348Bacitracin Zinc, Decoquinate Albac® / Deccox®, Broiler Finisher Medicated046-920Bacitracin Zinc Baciferm® - 10, Baciferm® - 25, Baciferm® - 40, Baciferm® -50047-933Bacitracin Zinc, Monensin, USP Coban® plus Baciferm®049-934Bacitracin Zinc, Clopidol Coyden 25® with Bacitracin Zinc065-015Bacitracin Zinc, Hydrocortisone Acetate,Neomycin Sulfate, Polymyxin B Sulfate Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment, Vetropolycin HC Ophthalmic Ointment065-016Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate Bac-Neo-Poly Ophthalmic Ointment, Vetropolycin Ophthalmic Ointment065-114Bacitracin Zinc, Neomycin Sulfate, Polymyxin BSulfateMycitracin® Sterile Ophthalmic Ointment065-313Bacitracin Zinc Baciferm® Soluble 50065-476Bacitracin Zinc, Hydrocortisone Acetate,Neomycin Sulfate, Polymyxin B SulfateCortisporin Veterinary Ophthalmic Ointment065-485Bacitracin Zinc, Neomycin Sulfate, Polymyxin BSulfateNeosporin Ophthalmic Ointment091-326Bacitracin Zinc, Decoquinate, Roxarsone3-Nitro® / Deccox® / Albac®096-933Bacitracin Zinc, Robenidine Hydrochloride Robenz® Plus Zn Bacitracin098-452Bacitracin Zinc Albac® 50 Type A Medicated Article105-758Amprolium, Bacitracin Zinc, Ethopabate,RoxarsoneAmprol HI-E® / Baciferm® / 3-Nitro®114-794Amprolium, Bacitracin Zinc, Ethopabate Baciferm® / Amprol HI-E® Premix123-154Bacitracin Zinc, Monensin Sodium, Roxarsone3-Nitro®-10 / Baciferm® / Coban® Premix126-052Bacitracin Zinc, Lasalocid, Roxarsone3-Nitro® / Avatec® / Baciferm®134-830Bacitracin Zinc, Monensin Sodium Albac® / Coban®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 6 of 70Number136-484Bacitracin Zinc, Carbarsone Baciferm® / Carb-O-Sep®137-536Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Bio-Cox®138-703Bacitracin Zinc, Monensin Sodium, Roxarsone3-Nitro® / Albac® / Coban®139-190Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Bio-Cox® / Baciferm®139-235Bacitracin Zinc, Salinomycin Sodium Baciferm® / Bio-Cox®140-865Bacitracin Zinc, Narasin Baciferm® / Albac®, Baciferm® / Monteban®141-083Bacitracin Zinc, Lasalocid Avatec® / Baciferm®141-109Bacitracin Zinc, Lasalocid Avatec® / Baciferm®141-146Bacitracin Zinc, Nicarbazin Nicarb® / Baciferm®141-181Bacitracin Zinc, Lasalocid Avatec® / Albac®200-086Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Sacox®200-089Bacitracin Zinc, Salinomycin Sodium Baciferm® / Sacox®200-143Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Baciferm® / Sacox®200-203Bacitracin Zinc, Carbarsone Albac® / Carb-O-Sep®200-204Bacitracin Zinc, Salinomycin Sodium Albac® / Bio-Cox®200-205Amprolium, Bacitracin Zinc, Ethopabate Albac® / Amprol Hi-E®200-206Bacitracin Zinc, Decoquinate, Roxarsone3-Nitro® / Albac® / Deccox®200-207Bacitracin Zinc, Clopidol, Roxarsone3-Nitro® / Albac® / Coyden 25®200-208Bacitracin Zinc, Lasalocid, Roxarsone Avatec® / 3-Nitro® / Albac®200-209Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Sacox®200-210Bacitracin Zinc, Salinomycin Sodium Albac® / Sacox®200-211Bacitracin Zinc, Monensin, Roxarsone3-Nitro® / Albac® / Coban®200-212Bacitracin Zinc, Robenidine Hydrochloride Albac® / Robenz®200-213Bacitracin Zinc, Decoquinate Albac® / Deccox®3-Nitro® / Albac® / Amprol Hi-E®200-214Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone200-215Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Bio-Cox®200-217Amprolium, Bacitracin Zinc, Ethopabate,3-Nitro® / Albac® / Amprol Hi-E®Roxarsone200-218Bacitracin Zinc, Clopidol Albac® / Coyden 25® / Albac®200-223Bacitracin Zinc Albac® 50 Type A Medicated Article031-555Balsam Peru Oil, Castor Oil, Trypsin Trypzyme® Aerosol039-583Balsam Peru Oil, Castor Oil, Trypsin Granulex Aerosol Spray044-759Bambermycins Flavomycin® 4095-543Amprolium, Bambermycins, Ethopabate Amprol HI-E® & Bambermycins, Amprol HI-E® / Flavomycin®3-Nitro® / Amprol HI-E® / Flavomycin®095-547Amprolium, Bambermycins, Ethopabate,Roxarsone095-548Amprolium, Bambermycins, Roxarsone3-Nitro® / Amprol / Flavomycin®3-Nitro® / Amprol / Flavomycin®095-549Amprolium, Bambermycins, Ethopabate,RoxarsoneFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 7 of 70Number098-340Bambermycins, Monensin Sodium Flavomycin® / Monensin098-341Bambermycins, Monensin, Roxarsone3-Nitro® / Coban® / Flavomycin®101-628Bambermycins, Roxarsone, Zoalene3-Nitro® / Flavomycin® / Zoalene101-629Bambermycins, Zoalene Flavomycin® / Zoalene112-687Bambermycins, Lasalocid, Roxarsone3-Nitro® / Avatec® / Flavomycin®130-185Amprolium, Bambermycins Flavomycin® / Amprolium130-661Bambermycins, Carbarsone Carb-O-Sep / Flavomycin®131-413Bambermycins Flavomycin® 0.4, Flavomycin® 2132-448Bambermycins Flavomycin®134-185Bambermycins, Roxarsone, Salinomycin Sodium3-Nitro® / Bio-Cox® / Flavomycin®134-284Bambermycins, Salinomycin Sodium Bio-Cox® / Flavomycin®137-483Bambermycins, Halofuginone Hydrobromide Flavomycin® / Stenorol®140-339Bambermycins, Nicarbazin Flavomycin®, Nicarb®140-843Bambermycins, Narasin, Roxarsone3-Nitro® / Flavomycin® / Monteban®140-845Bambermycins, Narasin Flavomycin® / Monteban®140-918Bambermycins, Halofuginone Hydrobromide Flavomycin® / Stenorol®140-942Bambermycins, Narasin, Nicarbazin Flavomycin® / Maxiban®141-034Bambermycins Gainpro® Type A Medicated Article141-129Bambermycins, Lasalocid Avatec® / Flavomycin®141-158Bambermycins, Diclazuril Clinacox™ / Flavomycin®200-080Bambermycins, Roxarsone, Salinomycin Sodium3-Nitro® / Flavomycin® / Sacox®200-080Bambermycins, Roxarsone, Salinomycin Sodium3-Nitro® / Flavomycin® / Sacox®200-083Bambermycins, Salinomycin Sodium Flavomycin® / Sacox®200-388Gentamicin Sulfate, Betamethason Valerate GB Topical Spray034-010Betamethasone Acetate, Betamethasone SodiumBetavet Soluspan SuspensionPhosphate034-267Betamethasone Acetate, Gentamicin Sulfate Gentocin® Durafilm Ophthalmic SolutionBetasone Aqueous Suspension049-185Betamethasone Dipropionate, BetamethasoneSodium Phosphate034-010Betamethasone Acetate, Betamethasone SodiumBetavet Soluspan SuspensionPhosphateBetasone Aqueous Suspension049-185Betamethasone Dipropionate, BetamethasoneSodium Phosphate046-821Betamethasone Valerate, Gentamicin Sulfate Gentocin® Otic Solution113-231Betamethasone Valerate, Gentamicin Sulfate Topagen® Ointment132-338Betamethasone Valerate, Gentamicin Sulfate Gentocin® Topical SprayOtomax®140-896Betamethasone Valerate, Clotrimazole,Gentamicin Sulfate200-183Betamethasone Valerate, Gentamicin Sulfate Gentavet® Otic Solution200-188Betamethasone Valerate, Gentamicin Sulfate Betagen™ Topical SprayFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 8 of 70NumberTri-Otic Ointment200-229Betamethasone Valerate, Clotrimazole,Gentamicin SulfateVetro-Max®200-283Betamethasone Valerate, Clotrimazole,Gentamicin SulfateGBC Ointment™200-287Betamethasone Valerate, Clotrimazole,Gentamicin Sulfate200-415Betamethasone Valerate, Gentamicin Sulfate Gentamicin Sulfate Topical Spray200-416Gentamicin sulfate and Betamethasone valerate Gentamicin Topical SprayAmforol® Suspension042-548Attapulgite, Bismuth Subcarbonate, KanamycinSulfate042-841Attapulgite, Bismuth Subcarbonate, KanamycinAmforol® Veterinary Oral TabletsSulfate034-705Boldenone Undecylenate Equipoise®140-872Bovine Somatotropin (Sometribove Zinc)Posilac 1 Step®035-016Bunamidine Hydrochloride Scolaban 400045-738Buquinolate, Lincomycin HydrochlorideLincomix® / Bonaid, Lincomycin & BuquinolateMonohydrate130-872Butacaine Sulfate, Nitrofurazone Nitrofurazone Anesthetic Dress.104-184Butamisole Hydrochloride Styquin132-533Butamisole Hydrochloride Styquin Parenteral 1.1%102-990Butorphanol Tartrate Torbutrol® Injection103-390Butorphanol Tartrate Torbutrol® Tablets135-780Butorphanol Tartrate Torbugesic®141-047Butorphanol Tartrate Torbugesic-SA®200-239Butorphanol Tartrate Dolorex®200-322Butorphanol Tartrate Butorphanol Tartrate Injection200-332Butorphanol Tartrate Butorphic™ Injection200-408Butorphanol Tartrate Butorphanol Tartrate Injection200-448Butorphanol Tartrate, Melengestrol Acetate,Heifermax® plus Optaflexx® and Rumensin®Monensin Sodium, Ractopamine Hydrochloride094-642Cambendazole Camvet Suspension Horse Wormer096-506Cambendazole Camvet Horse Wormer Pellets096-731Cambendazole Camvet Horse Wormer Paste 45%009-339Ammonium Chloride, Caramiphen Edisylate Carafen Cough Syrup, Carafen Cough Tablets041-061Carbadox Mecadox® Premix 10092-955Carbadox, Pyrantel Tartrate Banminth® / Mecadox®141-211Carbadox, Oxytetracycline Dihydrate Mecadox® 10 / Terramycin® 100, Mecadox® 10 / Terramycin®200, Mecadox® 10 / Terramycin® 50 039-646Bacitracin Methylene Disalicylate, Carbarsone Carb-O-Gain118-507Amprolium, Carbarsone Amprol® / Carb-O-Sep®130-661Bambermycins, Carbarsone Carb-O-Sep / Flavomycin®136-484Bacitracin Zinc, Carbarsone Baciferm® / Carb-O-Sep®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 9 of 70Number200-203Bacitracin Zinc, Carbarsone Albac® / Carb-O-Sep®038-879Carbarsone, Zoalene Carb-O-Sep® / Zoamix®038-879Carbarsone, Zoalene Carb-O-Sep® / Zoamix®032-946Carbomycin, Oxytetracycline Hydrochloride Magna Terramycin® Soluble Powder139-633Carfentanil Citrate Wildnil®139-879Carnidazole Carnidazole, Spartrix®141-053Carprofen Rimadyl® Caplets for Dogs141-111Carprofen Rimadyl® Chewable Tablets141-199Carprofen Rimadyl® Injectable200-366Carprofen Novocox Caplets200-397Carprofen Vetprofen™200-498Carprofen Carprieve™200-555Carprofen Librevia™031-555Balsam Peru Oil, Castor Oil, Trypsin Trypzyme® Aerosol039-583Balsam Peru Oil, Castor Oil, Trypsin Granulex Aerosol Spray119-688Cefadroxil Cefa-Tabs®140-684Cefadroxil Cefa-Drops®141-285Cefovecin sodium Convenia®141-232Cefpodoxime proxetil Simplicef®200-543Cefpodoxime proxetil Cefpodoxime Proxetil Tablets141-209Ceftiofur Crystalline Free Acid Excede™ Sterile Suspension141-235Ceftiofur Crystalline Free Acid Excede™ For Swine140-890Ceftiofur Hydrochloride Excenel Sterile Suspension, Excenel® RTU, Excenel® SterilePowder141-238Ceftiofur Hydrochloride Spectramast™ LC Sterile Suspension141-239Ceftiofur Hydrochloride Spectramast™ DC Sterile Suspension141-288Ceftiofur Hydrochloride Excenel® RTU EZ140-338Ceftiofur Sodium Naxcel® Sterile Powder200-420Ceftiofur Sodium Ceftiofur Sodium Sterile Powder200-421Ceftiofur sodium Ceftiofur for Injection141-326Cephalexin Rilexine® Chewable Tablets108-114Cephapirin Benzathine Cefa-Dri®, Tomorrow® Infusion097-222Cephapirin Sodium Cefa-Lak®, Today® Intramammary Infusion046-789Chloral Hydrate, Magnesium Sulfate, ChloropentPentobarbital055-002Chloramphenicol Tevcocin055-051Chloramphenicol Chloromycetin Tablets 100 mg, Chloromycetin Tablets 250 mg,Chloromycetin Tablets 500 mg055-059Chloramphenicol Viceton® Tablets065-137Chloramphenicol Amphicol-VFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 10 of 70Number065-149Chloramphenicol Chloromycetin Ophthalmic Ointment065-150Chloramphenicol Chloramphenicol Capsules065-241Chloramphenicol Mychel-Vet Capsules (50 mg)065-460Chloramphenicol Chloramphenicol 1% Ophthalmic, Vetrocloricin OphthalmicOintment065-461Chloramphenicol Anacetin Tablets065-463Chloramphenicol Mychel-Vet Injection065-489Chloramphenicol Mychel-Vet Tabs065-491Chloramphenicol Medichol Tablets055-047Chloramphenicol Palmitate Chloromycetin Palmitate Oral Suspension009-782Chlorhexidine Acetate Nolvasan® Antiseptic Ointment200-301Chlorhexidine Acetate Privasan™ Antiseptic Ointment009-809Chlorhexidine Hydrochloride Nolvasan® Cap-Tabs®010-434Chlorhexidine Hydrochloride Nolvasan® Suspension006-983Chlorobutanol, Doxylamine Succinate A-H Injection141-245Chloroquine Phosphate, Embutramid, Lidocaine Tributame™ Euthanasia Solution011-678Chlorothiazide Diuril® Tablet012-734Chlorothiazide Diuril®038-160Chlorphenesin Carbamate Maolate® Tablets, Maolate® Veterinary048-761Chlortetracycline Aureomycin® 100 Granular, Aureomycin® 50 Granular,Aureomycin® 90 Granular, Aureomycin® 90 Meal138-935Chlortetracycline Pennchlor™ 100MR, Pennchlor™ 50, Pennchlor™ 50-G,Pennchlor™ 90, Pennchlor™ 90-G, Pennchlor™ 100-G,Pennchlor™ 100 Hi-Flo141-059Bacitracin Methylene Disalicylate,Chlortetracycline BMD® 10, 25, 30, 40, 50, 60, 75 / CTC® 50, 65, 70, BMD® 25, 30, 40, 50, 60, 75 / ChlorMax™®- 50, 60, 70, MICRO-CTC® 100141-147Chlortetracycline, Decoquinate Chloromax® / Deccox®141-185Chlortetracycline, Decoquinate Aureomycin® / Deccox®141-201Chlortetracycline, Laidlomycin PropionatePotassiumAureomycin® / Cattlyst®141-250Chlortetracycline, Lasalocid Aureomycin® and Bovatec®200-259Chlortetracycline, Roxarsone, SalinomycinSodium3-Nitro® / ChlorMax™ / Sacox®200-260Chlortetracycline, Roxarsone, SalinomycinSodium3-Nitro® / Bio-Cox® / ChlorMax™200-261Chlortetracycline, Salinomycin Sodium Bio-Cox® / ChlorMax™200-262Chlortetracycline, Salinomycin Sodium ChlorMax™ / Sacox®200-263Chlortetracycline, Monensin Sodium ChlorMax™ / Coban®200-314Chlortetracycline, Sulfamethazine Pennchlor S®200-355Chlortetracycline, Roxarsone, SalinomycinSodiumPennchlor™ / Bio-Cox® / 3-Nitro®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 11 of 70。
食品添加剂中英文对照表
Calcium phosphates (i)Monocalcium phosphate (ii)Dicalcium phophate (iii)Tricalcium phosphate
59 E 222 Sodium hydrogen sulphite 60 E 223 Sodium metabisulphite 61 E 224 Potassium metabisulphite 62 E 226 Calcium sulphite 63 E 227 Calcium hydrogen sulphite 64 E 228 Potassium hydrogen sulphite 65 E 230 Biphenyl, diphenyl 66 E 231 Orthophenyl phenol 67 E 232 Sodium orthophenyl phenol 68 E 233 Thiabendazole 69 E 234 Nisin 70 E 235 Natamycin or pimaricin 71 E 239 Hexamethylene tetramine 72 E 242 Dimethyl dicarbonate 73 E 249 Potassium nitrite 74 E 250 Sodium nitrite 75 E 251 Sodium nitrate 76 E 252 Potassium nitrate 77 E 260 Acetic acid 78 E 261 Potassium acetate or potassium diacetate
阿拉丁L-精氨酸盐酸盐产品安全技术说明书
GHS07:感叹号在眼睛接触的情况下无数据资料如果误服用水雾，耐醇泡沫，干粉或二氧化碳灭火。
4.2最重要的症状和影响，急性的和滞后的最重要的症状和健康影响据我们所知，此化学，物理和毒性性质尚未经完整的研究。
4.3及时的医疗处理和所需的特殊处理的说明和指示如有必要，佩戴自给式呼吸器进行消防作业。
5消防措施5.1灭火介质火灾特征无数据资料灭火方法及灭火剂碳氧化物,氮氧化物,氯化氢气体5.2源于此物质或混合物的特别的危害避免粉尘生成。
避免吸入蒸气、气雾或气体。
5.3救火人员的预防无数据资料5.4进一步的信息无数据资料6泄露应急处理6.1人员的预防,防护设备和紧急处理程序扫掉和铲掉。
放入合适的封闭的容器中待处理。
6.2环境预防措施丢弃处理请参阅第5797节6.3抑制和清除溢出物的方法和材料在有粉尘生成的地方,提供合适的排风设备。
6.4参考其他部分贮存在阴凉处。
使容器保持密闭，储存在干燥通风处。
7安全操作与储存7.1安全操作的注意事项无数据资料7.2安全储存的条件,包括任何不兼容性无数据资料7.3特定用途常规的工业卫生操作。
8接触控制/个体防护8.1控制参数最高容许浓度成分 CAS No. 值控制参数基准L-精氨酸盐酸盐L-Arginine hydrochloride 1119-34-2PC-TWA请使用经官方标准如NIOSH(美国)或EN166(欧盟)检测与批准的设备防护眼部。
《工作场所有害因素职业接触限值》国家标准中的工作场所时间加权平均容许浓度无数据资料无数据资料 无数据资料8.2暴露控制适当的技术控制根据危险物质的类型，浓度和量，以及特定的工作场所选择身体保护措施。
,防护设备的类型必须根据特定工作场所中的危险物的浓度和数量来选择。
Sigma-Aldrich-A5131页码4的6人身保护设备眼/面保护无数据资料皮肤保护戴手套取手套在使用前必须受检查。
请使用合适的方法脱除手套(不要接触手套外部表面),避免任何皮肤部位接触此产品.使用后请将被污染过的手套根据相关法律法规和有效的实验室规章程序谨慎处理.请清洗并吹干双手身体保护无数据资料呼吸系统防护不需要保护呼吸。
艾拉光动力治疗系统
艾拉（5-ALA）
【通用名】：盐酸氨酮戊酸；外用盐酸氨酮戊酸散
【化学名】：5-氨基-4-酮戊酸盐酸盐
【英文名】：Aminolevulinic Acid Hydrochloride，ALA
ቤተ መጻሕፍቲ ባይዱ
【化学式】： C5H9NO3·HCl
O
O
NH+3Cl-
OH
【分子量】：167.59 【曾用名】：5-氨基酮戊酸盐酸盐、-氨基酮戊酸盐酸盐、-
➢ 艾拉光动力治疗后，疣体复发率明显低于CO2激光治疗
16
艾拉光动力治疗不良反应发生率低
17
联合治疗CA疗效优异
ALA-PDT联合CO2激光治疗尖锐湿疣疗效分析
复发例数
复发率
40
40%
36.25%
30
30%
29
20
20%
10
9.78%
10%
9
0 CO2激光组
0% 联合治疗组
联合治疗组：CO2激光＋2次ALA-PDT
靶组织坏死凋亡过程
光动力疗法（PDT）三要素
光敏剂（光动力治疗药物） 光敏剂是一些特殊的化学物质，其基本作用是传递能
量，它能够吸收光子而被激发，又将吸收的光能迅速传递 给另一组分的分子，使其被激发而光敏剂本身回到基态。 分子氧
光照射光敏剂形成的激发态光敏剂，与基态氧相互作 用，产生单线态氧，单态氧是氧化破坏生物大分子、最终 杀伤破坏肿瘤的关键性物质。 光源 大多采用激光光源、二极管发光光源（LED）等，激光的 波长、输出的功率，稳定性必须满足临床的要求
艾拉光动力治疗尖锐湿疣操作过程
溶解药物（艾拉）
20%艾拉溶液湿敷患处3小 时
635nm红光照射患 处